X

This site uses third parties to own and optimize your navigation and perform analytical work cookies. If you continue browsing, consider that you accept its use.
You can learn more at our Cookie Policy.

Innoprot

  • Innoprot
    • Productos
      • Human Primary Cells
        • Hepatic Cell System

Human Hepatic Sinusoidal Endothelial Cells

Reference: P10652


Get your Price

Data Sheet

Human Hepatic Sinusoidal Endothelial Cells (HHSEC) provided by Innoprot are isolated by ScienCell Research Laboratories from human liver. HHSEC are cryopreserved immediately after purification and delivered frozen. HHSEC are guaranteed to further expand for 15 population doublings in the conditions provided by ScienCell Research Laboratories.

Innoprot also offers optimized medium and reagents for the growth of Human Hepatic Sinusoidal Endothelial Cells which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro HSEC culture.

Features/Benefits


SEC are microvascular endothelial cells with a unique phenotype reminiscent of dendritic cells and a unique function as antigen-presenting cells for CD4+ T cells. Thus, SEC represent a new type of organ-resident "non-professional" antigen-presenting cell that appears to be involved in the local control of the immune response and the induction of immune tolerance in the liver. SEC express well-characterized surface receptors and differ morphologically and metabolically from large-vessel endothelia. It has reported that SEC are dynamic regulators of porosity that respond rapidly and locally to environmental zonal stimuli during liver regeneration. Due to its strategic position in the liver sinusoid, SEC dysfunction and structural alterations have far-reaching repercussions for the whole liver.

Number of Cells

  • 5x105 cells / vial

Related Products/Services



© Innoprot 2008 - Cell Based Assays for Drug Discovery Screening - Cookie Policy